Clinical Cell and Vaccine Production Facility (CVPF)
The Clinical Cell and Vaccine Production Facility (CVPF) renders bench-to-bedside translational medicine a reality. Equipped with state of the art facilities, the CVPF manufactures cell and gene biotherapeutics and has been accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) since 2008. As a shared resource within the Center for Cellular Immunotherapies (CCI) and the Division of Transfusion Medicine & Therapeutic Pathology within the Department of Pathology & Laboratory Medicine, the CVPF supports numerous investigational new drug (IND) protocols. Current protocols target a variety of disease indications (primarily HIV, adult and pediatric cancers, and stroke); many more trials are in development and, once approved, will further expand the scope of diseases targeted for cell and gene therapy. For more information on current trials, see our Clinical Trials page.
Recent News & Highlights
Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children’s Hospital of Philadelphia’s Transformative, Personalized Cancer Therapy
June 09, 2022
“Of Medicine and Miracles” details the journey of a team of doctors and a family who came together on the leading edge of a cancer cure
Study of Penn Patients with Decade-Long Leukemia Remissions after CAR T Cell Therapy Reveals New Details About Persistence of Personalized “Living Drug” Cells
Feb 2, 2022
Two patients represent longest-known CAR T cell response to date, providing insight into treatment effects and outcomes
Recent & Upcoming Events
The Believe Ball
09/17/2022
Where: Valley Forge Casino Resort, King of Prussia, PA Time: 6:00 – 10:00 p.m. Event Details: Cocktail Hour, Seated Dinner, Inspiring Patient Stories, Silent Auction, Kid-Friendly Activation Stations & more! https://emilywhiteheadfoundation.org/believe-ball/